{
    "2021-10-20": [
        [
            {
                "time": "2021-10-20",
                "original_text": "FDA Authorizes Mix-and-Match, J&J, and Moderna Boosters",
                "features": {
                    "keywords": [
                        "FDA",
                        "boosters",
                        "mix-and-match",
                        "J&J",
                        "Moderna"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-10-21",
                "original_text": "U.S. FDA clears Moderna, J&J COVID-19 boosters, backs use of different vaccine for boost",
                "features": {
                    "keywords": [
                        "FDA",
                        "clears",
                        "Moderna",
                        "J&J",
                        "boosters"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-10-22",
                "original_text": "Advisory Committee on Immunization Practices Votes to Recommend Routine Use of Pfizer’s PREVNAR 20™ (Pneumococcal 20-valent Conjugate Vaccine) in Adults",
                "features": {
                    "keywords": [
                        "Advisory Committee",
                        "Immunization Practices",
                        "Pfizer",
                        "PREVNAR 20",
                        "vaccine"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-10-23",
                "original_text": "Top Analyst Reports for Microsoft, Mastercard & Pfizer",
                "features": {
                    "keywords": [
                        "Analyst Reports",
                        "Microsoft",
                        "Mastercard",
                        "Pfizer"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "financial services",
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-24",
                "original_text": "Covid-19 Vaccine for Kids Ages 5-11 to Be Given at Pediatric Offices, Schools Once Authorized",
                "features": {
                    "keywords": [
                        "Covid-19 Vaccine",
                        "Kids",
                        "Pediatric Offices",
                        "Schools",
                        "Authorized"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "education"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-10-25",
                "original_text": "Pfizer Covid-19 vaccine is 93% effective against adolescent hospitalizations: CDC",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Covid-19",
                        "vaccine",
                        "effective",
                        "adolescent",
                        "CDC"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-10-26",
                "original_text": "Britain secures COVID-19 antivirals from Merck and Pfizer",
                "features": {
                    "keywords": [
                        "Britain",
                        "COVID-19",
                        "antivirals",
                        "Merck",
                        "Pfizer"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-10-27",
                "original_text": "Are Investors Undervaluing Pfizer (PFE) Right Now?",
                "features": {
                    "keywords": [
                        "Investors",
                        "Undervaluing",
                        "Pfizer",
                        "PFE"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-10-28",
                "original_text": "White House Lays Out Vaccine Rollout Plan for Kids Aged 5 to 11",
                "features": {
                    "keywords": [
                        "White House",
                        "Vaccine",
                        "Rollout Plan",
                        "Kids",
                        "Aged 5 to 11"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "government"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-10-29",
                "original_text": "5 Top Stock Gainers for Thursday: Ford, Pinterest, Pfizer",
                "features": {
                    "keywords": [
                        "Stock Gainers",
                        "Ford",
                        "Pinterest",
                        "Pfizer"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "automotive",
                        "technology",
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}